Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Improvement In Renal Function In Newly Diagnosed Myeloma Improves Survival, but Still Remains Inferior to Those with Normal Renal Function

Shaji Kumar, MD, Angela Dispenzieri, M.D., Martha Lacy, MD, Suzanne R. Hayman, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., Kristen Detweiler-Short, RN, John Lust, Steven Zeldenrust, MD, Stephen Russell, MD, PhD, Philip R. Greipp, MD, Robert Kyle, MD, Morie Gertz, MD, Vincent Rajkumar

Blood (2010) 116 (21): 2970.

https://doi.org/10.1182/blood.V116.21.2970.2970

Published: 2010

Journal Articles

Higher Plasma Cell Burden Predicts for Early Death In Patients with AL Amyloidosis

Cheng E. Chee, MD, S. Vincent Rajkumar, MD, Morie Abraham A Gertz, MD, Martha Lacy, MD, Steven Zeldenrust, MD, Shaji Kumar, MD, Suzanne R. Hayman, MD, Francis Buadi, MD, Stephen Russell, MD, PhD, Robert Kyle, MD, Philip R. Greipp, MD, Angela Dispenzieri, M.D.

Blood (2010) 116 (21): 1893.

https://doi.org/10.1182/blood.V116.21.1893.1893

Published: 2010

Journal Articles

A Phase-2 Study of Pomalidomide and Dexamethasone In Previously-Treated Light-Chain (AL) Amyloidosis

Blood (2010) 116 (21): 987.

https://doi.org/10.1182/blood.V116.21.987.987

Published: 2010

Journal Articles

Pomalidomide Plus Low-Dose Dexamethasone In Myeloma Refractory to Both Bortezomib and Lenalidomide: Comparison of Two Dosing Strategies In Dual-Refractory Disease

Blood (2010) 116 (21): 863.

https://doi.org/10.1182/blood.V116.21.863.863

Published: 2010

Journal Articles

Non-Clonal Serum Immunoglobulin Free Light Chains (FLC) as Markers of Overall Survival

Angela Dispenzieri, M.D., Robert Kyle, MD, Jerry A Katzmann, PhD, Dirk Larson, Shaji Kumar, MD, Graham Peter Mead, PhD, Arthur Bradwell, FRCP, FRCPath, S. Vincent Rajkumar, MD

Blood (2010) 116 (21): 3893.

https://doi.org/10.1182/blood.V116.21.3893.3893

Published: 2010

Journal Articles

Trend towards Improved Day 100 and 2-Year Survival After SCT for AL Amyloidosis: Outcomes Before and After 2006

Morie Abraham Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, M.D., Shaji Kumar, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., Nelson Leung, MD, William J Hogan, MBBCh, Suzanne R. Hayman, MD

Blood (2010) 116 (21): 3554.

https://doi.org/10.1182/blood.V116.21.3554.3554

Published: 2010

Journal Articles

Comparison of Troponin T and N-Terminal-Pro-Brain Natriuretic Peptides In Two Models of Treatment Related Mortality In AL Amyloidosis Patients Following Autologous Stem Cell Transplantation

Nelson Leung, MD, Shaji Kumar, MD, Angela Dispenzieri, M.D., Martha Lacy, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., William J Hogan, MBBCh, Dennis Gastineau, MD, Morie Gertz, MD

Blood (2010) 116 (21): 3572.

https://doi.org/10.1182/blood.V116.21.3572.3572

Published: 2010

Journal Articles

Unraveling Early Mortality In Patients with AL Amyloidosis

Cheng E. Chee, MD, Vincent Rajkumar, PhD, Morie Gertz, Martha Lacy, MD, Steven Zeldenrust, Shaji Kumar, MD, Suzanne R. Hayman, MD, Francis Buadi, MB, CHB, Stephen Russell, MD, PhD, Robert Kyle, MD, Philip R. Greipp, MD, Angela Dispenzieri, M.D.

Blood (2010) 116 (21): 4990.

https://doi.org/10.1182/blood.V116.21.4990.4990

Published: 2010

Journal Articles

Proteomic Analysis of Immunoglobulin Light Chains (LC) In AL Amyloidosis Shows That the Sequence of Clonal LC Secreted by the Neoplastic Plasma Cells Is Identical to the LC Deposited In the Amyloid Plaques

David L Murray, M.D., Ph.D., Jason D Theis, Julie A. Vrana, Ph.D., Marina Ramirez-Alvarado, Ph.D., Roshini Abraham, Ph.D., Angela Dispenzieri, M.D., Jerry A Katzmann, PhD, Ahmet Dogan, M.D., Ph.D.

Blood (2010) 116 (21): 1909.

https://doi.org/10.1182/blood.V116.21.1909.1909

Published: 2010

Journal Articles

IgM Multiple Myeloma: Disease Definition, Prognosis, and Differentiation From Waldenstrom's Macroglobulinemia.

Steven Schuster, MD, Angela Dispenzieri, M.D., S. Vincent Rajkumar, M.D., Alvaro Moreno Aspitia, Assistant, Professor, of, Medici, Robert Kyle, M.D., Joseph R. Mikhael, MD

Blood (2009) 114 (22): 1828.

https://doi.org/10.1182/blood.V114.22.1828.1828

Published: 2009

Journal Articles

Isotype-Specific Heavy/Light Chain (HLC) Suppression as a Predictor of Myeloma Development in Monoclonal Gammopathy of Undetermined Significance (MGUS).

Jerry Katzmann, PhD, Raynell Clark, Angela Dispenzieri, M.D., Robert Kyle, MD, Ola Landgren, M.D., Ph.D., Arthur Bradwell, FRCP, FRCPath, S. Vincent Rajkumar, MD

Blood (2009) 114 (22): 1788.

https://doi.org/10.1182/blood.V114.22.1788.1788

Published: 2009

Journal Articles

Clinical Features and Treatment Response of Light Chain (AL) Amyloidosis Diagnosed in Patients with Previous Diagnosis of Multiple Myeloma (MM).

Sumit Madan, M.D., Angela Dispenzieri, M.D., Martha Q. Lacy, MD, Francis Buadi, M.D., Suzanne R. Hayman, MD, Kristin Detweiler, R.N., C.N.P, Steven R. Zeldenrust, M.D., Ph.D., David Dingli, M.D., PhD., Philip R Greipp, M.D., Stephen J. Russell, MD, PhD, John A. Lust, MD, PhD, Robert A Kyle, MD, S. Vincent Rajkumar, M.D., Morie A Gertz, M.D., Shaji K Kumar, MD

Blood (2009) 114 (22): 4867.

https://doi.org/10.1182/blood.V114.22.4867.4867

Published: 2009

Journal Articles

Retrospective Study of the Efficacy of Bortezomib in Primary Systemic Amyloidosis.

Francis Buadi, MD, Martha Q. Lacy, MD, Angela Dispenzieri, M.D., Shaji Kumar, Suzanne Hayman, MD, Kristen E Detweiler Short, R.N., C.N.P., David Dingli, M.D., PhD., Steven R. Zeldenrust, M.D., Ph.D., Philip R. Greipp, MD, John A. Lust, MD, PhD, Stephen J. Russell, MD, PhD, Robert Kyle, M.D., Vincent Rajkumar, MD, Morie A Gertz, MD

Blood (2009) 114 (22): 4953.

https://doi.org/10.1182/blood.V114.22.4953.4953

Published: 2009

Journal Articles

The Biologic and Analytic Variability of Serum Protein Electrophoresis M-Spike, Nephelometric Ig Quantitation, Serum FLC Quantitation, and Urine M-Spike in Monoclonal Gammopathies.

Melissa Snyder, Angela Dispenzieri, M.D., S.Vincent Rajkumar, M.D., Robert Kyle, M.D., Joanne Benson, BA, Jerry A. Katzmann, PhD

Blood (2009) 114 (22): 1803.

https://doi.org/10.1182/blood.V114.22.1803.1803

Published: 2009

Journal Articles

Evidence for Ongoing DNA Damage in Multiple Myeloma as Revealed by Constitutive Phosphorylation of H2AX.

Denise K. Walters, PhD, Renee C. Tschumper, Xiaosheng Wu, M.D., Kimberly J. Henderson, Angela Dispenzieri, M.D, Diane F. Jelinek, PhD

Blood (2009) 114 (22): 2817.

https://doi.org/10.1182/blood.V114.22.2817.2817

Published: 2009

Journal Articles

Phase II Study of Melphalan, Prednisone and Lenalidomide Combination for Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplantation

Vivek Roy, MD, FACP, A. Keith Stewart, MBChB, MBA, P. Leif Bergsagel, MD, Angela Dispenzieri, M.D., Kristina Laumann, Jake Allred, Martha Q. Lacy, MD, Rafael Fonseca, MD, Craig B. Reeder, MD, Shaji Kumar, MD, Candido E. Rivera, MD, Morie A. Gertz, MD, Philip R. Greipp, MD, Francis K. Buadi, MD, Suzanne R. Hayman, MD, S. Vincent Rajkumar, MD

Blood (2008) 112 (11): 2769.

https://doi.org/10.1182/blood.V112.11.2769.2769

Published: 2008

Journal Articles

Outcome of Patients with IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplants: A Retrospective CIBMTR Study.

Donna E. Reece, MD, David H. Vesole, MD, PhD, Smriti Shrestha, MS, MA, Angela Dispenzieri, M.D., Gustavo Milone, MD, Waleska S. Peréz, MPH, Mei-Jie Zhang, PhD, Parameswaran Hari, MD, MS

Blood (2008) 112 (11): 3328.

https://doi.org/10.1182/blood.V112.11.3328.3328

Published: 2008

Journal Articles

Immunoglobulin Light Chain Gene Constant Region Is An Invariable Part of Amyloid Deposits in AL Amyloidosis

Jason D. Theis, Julie A. Vrana, Ph.D., Jeffrey D. Gamez, Angela Dispenzieri, M.D., Stephen R. Zeldenrust, M.D., Ph.D., Ahmet Dogan, M.D., Ph.D.

Blood (2008) 112 (11): 3128.

https://doi.org/10.1182/blood.V112.11.3128.3128

Published: 2008

Journal Articles

Allogeneic HSC Transplantation for Multiple Myeloma: A Single Institution Experience.

Luciano J. Costa, MD, PhD, Shaji Kumar, M.D., Angela Dispenzieri, M.D., Suzanne E. Hayman, M.D., Francis K. Buadi, M.D., Mark R. Litzow, M.D., Morrie A. Gertz, M.D., Martha Q. Lacy, M.D.

Blood (2007) 110 (11): 3036.

https://doi.org/10.1182/blood.V110.11.3036.3036

Published: 2007

Journal Articles

Transplantation without Growth Factor. Engraftment Kinetics Following Stem Cell Transplantation for Primary Systemic Amyloidosis.

Morie Abraham Gertz, MD, Martha Q. Lacy, M.D., Angela Dispenzieri, M.D., Suzanne R. Hayman, M.D., Shaji K. Kumar, M.D., Dennis A. Gastineau, M.D.

Blood (2006) 108 (11): 2956.

https://doi.org/10.1182/blood.V108.11.2956.2956

Published: 2006

NARROW

Improvement In Renal Function In Newly Diagnosed Myeloma Improves Survival, but Still Remains Inferior to Those with Normal Renal Function

Higher Plasma Cell Burden Predicts for Early Death In Patients with AL Amyloidosis

A Phase-2 Study of Pomalidomide and Dexamethasone In Previously-Treated Light-Chain (AL) Amyloidosis

Pomalidomide Plus Low-Dose Dexamethasone In Myeloma Refractory to Both Bortezomib and Lenalidomide: Comparison of Two Dosing Strategies In Dual-Refractory Disease

Non-Clonal Serum Immunoglobulin Free Light Chains (FLC) as Markers of Overall Survival

Trend towards Improved Day 100 and 2-Year Survival After SCT for AL Amyloidosis: Outcomes Before and After 2006

Comparison of Troponin T and N-Terminal-Pro-Brain Natriuretic Peptides In Two Models of Treatment Related Mortality In AL Amyloidosis Patients Following Autologous Stem Cell Transplantation

Unraveling Early Mortality In Patients with AL Amyloidosis

Proteomic Analysis of Immunoglobulin Light Chains (LC) In AL Amyloidosis Shows That the Sequence of Clonal LC Secreted by the Neoplastic Plasma Cells Is Identical to the LC Deposited In the Amyloid Plaques

IgM Multiple Myeloma: Disease Definition, Prognosis, and Differentiation From Waldenstrom's Macroglobulinemia.

Isotype-Specific Heavy/Light Chain (HLC) Suppression as a Predictor of Myeloma Development in Monoclonal Gammopathy of Undetermined Significance (MGUS).

Clinical Features and Treatment Response of Light Chain (AL) Amyloidosis Diagnosed in Patients with Previous Diagnosis of Multiple Myeloma (MM).

Retrospective Study of the Efficacy of Bortezomib in Primary Systemic Amyloidosis.

The Biologic and Analytic Variability of Serum Protein Electrophoresis M-Spike, Nephelometric Ig Quantitation, Serum FLC Quantitation, and Urine M-Spike in Monoclonal Gammopathies.

Evidence for Ongoing DNA Damage in Multiple Myeloma as Revealed by Constitutive Phosphorylation of H2AX.

Phase II Study of Melphalan, Prednisone and Lenalidomide Combination for Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplantation

Outcome of Patients with IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplants: A Retrospective CIBMTR Study.

Immunoglobulin Light Chain Gene Constant Region Is An Invariable Part of Amyloid Deposits in AL Amyloidosis

Allogeneic HSC Transplantation for Multiple Myeloma: A Single Institution Experience.

Transplantation without Growth Factor. Engraftment Kinetics Following Stem Cell Transplantation for Primary Systemic Amyloidosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only